The technology that produced a global scandal in China last year has entered into clinical trials to treat sickle cell anemia and an eye disease.
Despite Controversy, Human Studies of CRISPR Move Forward in the U.S.
Posted in biotech/medical
Posted in biotech/medical
The technology that produced a global scandal in China last year has entered into clinical trials to treat sickle cell anemia and an eye disease.